Literature DB >> 33343718

The management of infected shoulder arthroplasty by two-stage revision.

Matthew Brown1, Kelechi Eseonu1, Will Rudge1, Simon Warren1,2,3, Addie Majed1, Ian Bayley1, Deborah Higgs1, Mark Falworth1.   

Abstract

BACKGROUND: There remains no gold standard management for deep shoulder periprosthetic joint infection (PJI). This case series aims to present our experience of two-stage revision arthroplasty, including eradication of infection and reoperation rates.
METHODS: We retrospectively reviewed patients undergoing revision arthroplasty for shoulder PJI between 2006 and 2015. Cases were confirmed using Musculoskeletal Infection Society (MSIS) and American Academy of Orthopaedic Surgeons (AAOS) guidelines. TSA removal, debridement and irrigation preceded antibiotic-loaded cement spacer insertion and a minimum of six weeks intravenous antibiotics. Reimplantation was performed as a second stage following a negative aspirate.
RESULTS: Twenty-eight patients underwent a first stage procedure (mean age 69 years; 16 male, 12 female). Propionibacterium acnes, Methicillin-sensitive Staphylococcus aureus, Coagulase-negative Staphylococcus and Staphylococcus epidermidis were the commonest microorganisms cultured. Five cases had mixed growths and six cases provided no growth. Three patients did not proceed to a second stage. Twenty-five patients underwent reimplantation (mean interval 6.7 months), with 80% remaining infection-free (mean follow-up 38.3 months). DISCUSSION: Managing complex and late presentation shoulder PJI with two-stage revision is associated with high rates of infection eradication (80%). In the absence of a management consensus, our experience supports two-stage revision arthroplasty for eradicating infection in this complex patient group.
© 2019 The British Elbow & Shoulder Society.

Entities:  

Keywords:  infection eradication; periprosthetic joint infection; reimplantation; revision shoulder arthroplasty; total shoulder arthroplasty; total shoulder replacement; two-stage revision arthroplasty

Year:  2019        PMID: 33343718      PMCID: PMC7726183          DOI: 10.1177/1758573219841057

Source DB:  PubMed          Journal:  Shoulder Elbow        ISSN: 1758-5732


  71 in total

Review 1.  Inflammatory blood laboratory levels as markers of prosthetic joint infection: a systematic review and meta-analysis.

Authors:  Elie Berbari; Tad Mabry; Geoffrey Tsaras; Mark Spangehl; Pat J Erwin; Mohammad Hassan Murad; James Steckelberg; Douglas Osmon
Journal:  J Bone Joint Surg Am       Date:  2010-09-01       Impact factor: 5.284

2.  Leukocyte esterase in the diagnosis of shoulder periprosthetic joint infection.

Authors:  Gregory N Nelson; E Scott Paxton; Alexa Narzikul; Gerald Williams; Mark D Lazarus; Joseph A Abboud
Journal:  J Shoulder Elbow Surg       Date:  2015-09       Impact factor: 3.019

3.  The outcome of resection shoulder arthroplasty for recalcitrant shoulder infections.

Authors:  Jonathan P Braman; Mark Sprague; Julie Bishop; Ian K Lo; Edward W Lee; Evan L Flatow
Journal:  J Shoulder Elbow Surg       Date:  2006-08-07       Impact factor: 3.019

4.  Outcomes analysis of revision total shoulder replacement.

Authors:  Joshua S Dines; Stephen Fealy; Eric J Strauss; Answorth Allen; Edward V Craig; Russell F Warren; David M Dines
Journal:  J Bone Joint Surg Am       Date:  2006-07       Impact factor: 5.284

5.  Anaerobic thioglycolate broth culture for recovery of Propionibacterium acnes from shoulder tissue and fluid specimens.

Authors:  Samantha K Shannon; Jayawant Mandrekar; Daniel R Gustafson; Stefanea L Rucinski; Aaron L Dailey; Robert E Segner; Mindy K Burman; Kerri J Boelman; David T Lynch; Jon E Rosenblatt; Robin Patel
Journal:  J Clin Microbiol       Date:  2013-02       Impact factor: 5.948

6.  Can this prosthesis be saved?: implant salvage attempts in infected primary TKA.

Authors:  Jeremy Gardner; Terence J Gioe; Penny Tatman
Journal:  Clin Orthop Relat Res       Date:  2011-04       Impact factor: 4.176

7.  Revision surgery of reverse shoulder arthroplasty.

Authors:  Pascal Boileau; Barbara Melis; David Duperron; Grégory Moineau; Adam P Rumian; Yung Han
Journal:  J Shoulder Elbow Surg       Date:  2013-05-22       Impact factor: 3.019

8.  Prolonged bacterial culture to identify late periprosthetic joint infection: a promising strategy.

Authors:  Peter Schäfer; Bernd Fink; Dieter Sandow; Andreas Margull; Irina Berger; Lars Frommelt
Journal:  Clin Infect Dis       Date:  2008-12-01       Impact factor: 9.079

9.  Antimicrobial peptides and proinflammatory cytokines in periprosthetic joint infection.

Authors:  Hans Gollwitzer; Yvonne Dombrowski; Peter M Prodinger; Mark Peric; Burkhard Summer; Alexander Hapfelmeier; Belma Saldamli; Felix Pankow; Rüdiger von Eisenhart-Rothe; Andreas B Imhoff; Jürgen Schauber; Peter Thomas; Rainer Burgkart; Ingo J Banke
Journal:  J Bone Joint Surg Am       Date:  2013-04-03       Impact factor: 5.284

10.  Propionibacterium acnes in primary shoulder arthroplasty: rates of colonization, patient risk factors, and efficacy of perioperative prophylaxis.

Authors:  Chuan Kong Koh; Jonathan P Marsh; Dragana Drinković; Cameron G Walker; Peter C Poon
Journal:  J Shoulder Elbow Surg       Date:  2015-12-15       Impact factor: 3.019

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.